SynthesisScientific reports2019

Safety of low-dose subcutaneous recombinant interleukin-2: systematic review and meta-analysis of randomized controlled trials.

Seyed Hamidreza Mahmoudpour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.